These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27668453)

  • 1. Usefulness of fecal calprotectin determination in pediatric intestinal diseases.
    Rosso C; Caviglia GP; Pellicano R
    Minerva Pediatr; 2016 Dec; 68(6):478-486. PubMed ID: 27668453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.
    Sipponen T; Kolho KL
    Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
    Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
    Ikhtaire S; Shajib MS; Reinisch W; Khan WI
    J Gastroenterol; 2016 May; 51(5):434-46. PubMed ID: 26897740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
    Konikoff MR; Denson LA
    Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z; Durackova Z
    Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances in the role of fecal calprotectin in intestinal development and diseases among children].
    Li F; Sheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):1064-9. PubMed ID: 25344194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Di Ruscio M; Vernia F; Ciccone A; Frieri G; Latella G
    Inflamm Bowel Dis; 2017 Dec; 24(1):78-92. PubMed ID: 29272479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calprotectin or Lactoferrin: Do They Help.
    Wright EK
    Dig Dis; 2016; 34(1-2):98-104. PubMed ID: 26982329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.
    Hämäläinen A; Sipponen T; Kolho KL
    World J Gastroenterol; 2011 Dec; 17(47):5166-71. PubMed ID: 22215940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pediatrics. Fecal calprotectin in children: use and interpretation].
    Ezri J; Nydegger A
    Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance With Fecal Calprotectin Testing in Pediatric Patients With Inflammatory Bowel Disease.
    Queliza K; Wang MK; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):932-933. PubMed ID: 29135821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Faecal calprotectin : a useful tool for the primary care physician ?].
    D'angelo F; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1752-1756. PubMed ID: 28692215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
    Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
    Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
    Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
    Fraga M; Godat S; Nydegger A; Moradpour D; Schoepfer AM
    Rev Med Suisse; 2012 Sep; 8(352):1669-70, 1672-3. PubMed ID: 22988727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.